Aurobindo Pharma Limited (AUROPHARMA.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 757.64B |
| Enterprise Value | 739.67B |
| P/E Ratio | 25.45 |
| PEG Ratio | 28.72 |
| Price/Sales Ratio | 2.63 |
| Price/Book Ratio | 2.35 |
| Enterprise/Revenue | 2.57 |
| Enterprise/EBITDA | 12.07 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.1 |
| Operating Margin | 0.22 |
AD
Management Effectiveness
| Return On Assets | 0.06 |
| Return On Equity | 0.1 |
Income Statement
| Revenue | 336.53B |
| Revenue/Share | 579.36 |
| Gross Profit | 131.96B |
| EBITDA | 72.74B |
| Net Income | 35.05B |
| Diluted EPS | 60.34 |
Balance Sheet
| Total Cash | 106.18B |
| Total Cash/Share | 182.79 |
| Total Debt | 80.73B |
| Total Debt/Equity | 0.21 |
| Current Ratio | 1.81 |
| Book Value Per Share | 652.17 |
Price History
| 52-Week Change | 39.66 |
| 52-Week High | 1,550 |
| 52-Week Low | 1,016.1 |
| Moving Average 50 Days | 1,444.33 |
| Moving Average 200 Days | 1,252.58 |
Statistics
| Average Volume | 1.48M |
| Shares Outstanding | 575.38M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 4 |
| Trailing Annual Dividend Yield | 0.26 |
| Payout Ratio | 0.07 |
| Last Split Factor | 2:1 |
| Last Split Date | July 20, 2015 |
AD
